Taysha Gene Therapies, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TSHA for the last quarter is 1.79 M USD, and it's 60.79% higher compared to the previous quarter. The net income of Q3 24 is -25.52 M USD.